stars 1 stars 2 stars 3

Acta is helping to redefine how Alzheimer’s disease is treated and prevented by advancing the breakthrough discoveries of renowned Harvard Medical School-Massachusetts General Hospital neuroscientist and Acta’s scientific founder, Dr. Rudolph E. Tanzi. Acta’s pipeline leverages more than 40 years of Dr. Tanzi’s scientific accomplishments and $70 million in research and corporate funding to create safe, effective therapies that are affordable and accessible. Created in 2022, the Boston-based company is currently investigating GSM-779690T, a next-generation gamma-secretase modulator (GSM) designed for the treatment and potential prevention of Alzheimer’s disease, in clinical studies.

Website http://www.actapharmaceuticals.com
Employees 3 (2 on RocketReach)
Founded 2022
Phone +1 1508243854
Industry Pharmaceutical Manufacturing

Acta Pharmaceuticals Questions

George Alex is the CEO of Acta Pharmaceuticals.

2 people are employed at Acta Pharmaceuticals.

Top Acta Pharmaceuticals Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users